首页    期刊浏览 2024年10月04日 星期五
登录注册

文章基本信息

  • 标题:( Z )-2-(Benzo[ d ]thiazol-2-ylamino)-5-(substituted benzylidene)thiazol-4(5 H )-one Derivatives as Novel Tyrosinase Inhibitors
  • 本地全文:下载
  • 作者:Kyeong Ha Kang ; Bonggi Lee ; Sujin Son
  • 期刊名称:Biological and Pharmaceutical Bulletin
  • 印刷版ISSN:0918-6158
  • 电子版ISSN:1347-5215
  • 出版年度:2015
  • 卷号:38
  • 期号:8
  • 页码:1227-1233
  • DOI:10.1248/bpb.b15-00300
  • 出版社:The Pharmaceutical Society of Japan
  • 摘要:Inhibiting tyrosinase is an important goal to prevent melanin accumulation in skin and thereby to inhibit pigmentation disorders. Therefore, tyrosinase inhibitors are an attractive target in cosmetics and treatments for pigmentation disorders. However, only a few tyrosinase inhibitors are currently available because of their toxic effects to skin or lack of selectivity and stability. Here, we newly synthesized thirteen ( Z )-2-(benzo[ d ]thiazol-2-ylamino)-5-(substituted benzylidene)thiazol-4(5 H )-one derivatives and examined their effect on melanogenesis. Of these compounds, MHY2081 had the strongest inhibitory effect on tyrosinase without cytotoxicity in B16F10 melanoma cells. Consistently, melanogenesis was notably decreased by MHY2081 treatment. As an underlying mechanism, docking simulation showed that compared to kojic acid, a well-known competitive tyrosinase inhibitor which forms a hydrogen bond and aromatic interaction with tyrosinase, MHY2081 has stronger affinity with tyrosinase by forming three hydrogen bonds and a hydrophobic interaction with residues of tyrosinase. In parallel with this, Lineweaver–Burk plot analysis showed that MHY2081 is a strong competitive inhibitor of tyrosinase. In conclusion, MHY2081 may be a novel tyrosinase inhibitor for prevention and treatment of pigmentation disorders.
国家哲学社会科学文献中心版权所有